K M C Speciality Hospitals (India) logo

K M C Speciality Hospitals (India) MD, chairman, board of directors and AGM

NSE: KMCSHILBSE: 524520Healthcare ServicesSmall Cap

Last close ₹143.42down ₹8.10 (5.35%)BSE ₹144.20

Share price at the NSE close on 23 Oct 2026. Previous close ₹151.52.

52-week range of BSE trades to 23 Oct 2026
₹68.26Low, 28 Oct 2025₹185.70High, 8 Oct 2026
Market cap
₹2,339 Cr1,285th largest listed
P/E
41.9
P/B
11.1
Dividend yield
Nonein the last 12 months
ROE
29.8%
ROCE
27.5%
Debt to equity
0.34
Volume, NSE
5,64,66835.5% delivered

K M C Speciality Hospitals (India) board of directors

At the end of the quarter to Jun 2026, as the company filed it; changes since are in its announcements.Their trades in its shares

  • ChairpersonChandrakumar S
  • Managing directorSelvaraj Manivannan
  • Company Secretary and Compliance OfficerIndumathi P

8 directors4 independent2 executive2 non-executive

  • Chandrakumar S · ChairpersonExecutive · joined May 2011 · reappointed Sep 2024 · 1 listed board · 1 committee seat
  • Selvaraj Manivannan · Managing directorExecutive · joined Jul 2013 · reappointed Oct 2024 · 1 listed board · 3 committee seats
  • Thirunavukarasu SenthilkumarNon-executive · joined Sep 2016 · 1 listed board
  • Sundararaju VijayabaskaranNon-executive · joined Aug 2023 · 1 listed board
  • Sunil Satyapal GulatiIndependent · joined Apr 2024 · reappointed Apr 2024 · 27 months as independent · 3 listed boards · 3 as independent · 3 committee seats, 2 as chair
  • Purushothaman RavichandranIndependent · joined Apr 2024 · reappointed Apr 2024 · 27 months as independent · 1 listed board · 1 as independent · 2 committee seats
  • Srinivasan MohanIndependent · joined Aug 2024 · reappointed Aug 2024 · 22 months as independent · 1 listed board · 1 as independent
  • Narayanasami JeyantheiIndependent · joined Aug 2018 · reappointed Aug 2023 · 94 months as independent · 1 listed board · 1 as independent · 1 committee seat, 1 as chair

An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.

Committees and meetings

Who sits on each, and how often they met.Board meeting notices and outcomes

  • Board

    • 29 May 20264 of 8 present4 independent · 106 days in between
    • 11 Feb 20264 of 8 present4 independent

  • Audit Committee

    Chair Sunil Satyapal Gulati

    Purushothaman Ravichandran, Selvaraj Manivannan

    • 28 May 20263 of 3 present2 independent · 106 days in between
    • 10 Feb 20263 of 3 present2 independent

  • Nomination and remuneration committee

    Chair Sunil Satyapal Gulati

    Purushothaman Ravichandran, Thirunavukarasu Senthilkumar

    No meeting listed in the filing.

  • Stakeholders Relationship Committee

    Chair Narayanasami Jeyanthei

    Chandrakumar S, Selvaraj Manivannan

    • 28 May 20263 of 3 present1 independent · 106 days in between
    • 10 Feb 20263 of 3 present1 independent

  • Risk Management Committee

    Chair Selvaraj Manivannan

    Sunil Satyapal Gulati, Duraisamy Senguttuvan

    • 26 Feb 20262 of 2 present1 independent

  • Corporate Social Responsibility Committee

    Chair Chandrakumar S

    Selvaraj Manivannan, Purushothaman Ravichandran

    • 10 Feb 20263 of 3 present1 independent

  • Borrowing and Banking Committee

    Chandrakumar S, Selvaraj Manivannan, Sundararaju Vijayabaskaran

    No meeting listed in the filing.

Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.

Statutory auditor

Named in the results for the quarter to Mar 2026.

  • Deloitte Haskins & SellsPeer-review certificate valid to Apr 2028

A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.

K M C Speciality Hospitals (India) AGM and shareholder votes

Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.K M C Speciality Hospitals (India) share news and announcements

Annual general meeting, 28 Sep 2026

91,735 shareholders on the register on 21 Sep 2026; present: 1 promoter and 59 others; votes counted by M. Alagar / Alagar & Associates LLP.The company's voting result (opens in a new tab)

  1. To consider and adopt the Audited Financial Statements of the Company for the financial year ended March 31, 2026 together with the Reports of the Board of Directors and the Auditor thereon.
    OrdinaryPromoters have an interest in it
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 80.73% · promoters 100.00% · institutions 17.07% · other public 22.95%

  2. To appoint a Director in place of Dr. S Vijayabaskaran (DIN: 05139565), who retires by rotation and being eligible, offers himself for re-appointment.
    Ordinary
    99.98% for0.02% against

    Against: promoters 0.00% · institutions 93.58% · other public 0.00%

    Turnout: all 80.73% · promoters 100.00% · institutions 17.07% · other public 22.95%

  3. To approve Material Related Party Transactions under Section 188 of the Companies Act, 2013 and Regulation 23 of the SEBI (LODR) Regulations, 2015 with Sri Kauvery Medical Care (India) Limited, Holding CompanyMoreLess
    OrdinaryPromoters have an interest in it
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 2.04% · other public 0.00%

    Turnout: all 5.70% · promoters 0.00% · institutions 17.07% · other public 22.83%

  4. Ratification of remuneration to Cost Auditor for the financial year 2026-27
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 80.73% · promoters 100.00% · institutions 17.07% · other public 22.95%

  5. To approve limits of borrowing under section 180 (1) (c) and 180 (1) (a) of the Companies Act, 2013
    Special
    99.98% for0.02% against

    Against: promoters 0.00% · institutions 95.61% · other public 0.00%

    Turnout: all 80.73% · promoters 100.00% · institutions 17.07% · other public 22.95%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

How mutual funds voted

Fund houses must disclose how they vote at every meeting of a company they hold.

Mutual fund votes, meeting of 26 Sep 2025, 2 fund houses

  • Ratification of remuneration of Rs. 72,000/- plus applicable tax and reimbursement of out of pocket expenses for the financial year 2025-26, as approved by the Board of Directors of the Company, payable to M/s G Sugumar and Co, Cost Accountants (Registration No. 102522), Chennai, appointed by the Board as Cost Auditors to conduct the audit of the cost records of the Company for the financial year 2025-26.MoreLess
    2 for0 against
  • To appoint a Director in place of Dr. T Senthil Kumar (DIN: 01742558), who retires by rotation and being eligible, offers himself for re-appointment.
    2 for0 against
  • To approve Material Related Party Transactions under Section 188 of the Companies Act, 2013 and Clause 23 of the SEBI (LODR) Regulations, 2015 with Sri Kauvery Medical Care (India) Limited, Holding Company for availing and rendering of hospital services, purchase of goods, sale of goods, rental expenses, rental income, guarantee expenses, guarantee income, sale of asset, purchase of asset etc. or any transaction involving transfer of resources, services or obligations of whatever nature on such terms as may be mutually agreed upon for an aggregate value not exceeding Rs. 40,00,00,000/-.MoreLess
    Against Bandhan Mutual Fund
    • Bandhan Mutual Fund"The transactions include availing and rendering of hospital services, purchase and sale of goods, rental income and expenses, guarantee income and expenses, purchase and sale of assets, and any other transfer of resources, services, or obligations. The scope of the resolution is very enabling in nature. Kauvery Hospitals group operates 12 hospitals, of which two units in Trichy are housed under KMC Speciality Hospitals (India) Limited and the remaining 10 are held under the parent company, Sri Kauvery Medical Care (India) Limited. While the holding company, being of significant size, extends operational and financial support to the subsidiary, the rationale for the reverse arrangement where the listed subsidiary provides guarantees on behalf of the holding company is unclear. Further, there is no clarity on the terms of such support. As per the annual report, the outstanding guarantees extended for the holding company aggregated Rs. 800.0 mn as of 31 March 2025, of which Rs. 536.0 mn was extended during the year. These guarantees were provided to bankers on behalf of the holding company. Given the enabling nature of the resolution and the lack of clarity on the rationale for providing financial support, we do not support the resolution."
    1 for1 against
  • To consider and adopt the Audited Financial Statements of the Company for the financial year ended 31st March 2025 together with the Reports of the Board of Directors and the Auditor thereon.
    2 for0 against
  • To consider appointment of M/s. Alagar and Associates LLP (Firm No. L2025TN019200), Practicing Company Secretaries, Chennai as the Secretarial Auditors of the Company for first term of five consecutive financial years commencing from FY 2025-26 to FY 2029-30, who shall hold office from the conclusion of this 42nd AGM till the conclusion of the 47th AGM to be held in the year 2030, at such remuneration as may be mutually agreed between the Board of Directors and the Secretarial Auditor plus applicable taxes in addition to the travelling and out of pocket expenses.MoreLess
    2 for0 against

Mutual fund votes, meeting of 22 Mar 2025, 2 fund houses

  • To approve Material Related Party Transactions between KMC Speciality Hospitals (India) Limited (the Company) and Sri Kauvery Medical Care (India) Limited (Holding Company) for an aggregate value not exceeding Rs. 30,00,00,000/-.MoreLess
    2 for0 against
4 earlier meetings

Mutual fund votes, meeting of 27 Sep 2024, 2 fund houses

  • Appointment of Mr. Mohan Srinivasan (DIN: 00277477) as a Non - Executive Independent Director of the Company for a period of 3 (three) years with effect from 29th August 2024 till 28th August 2027 and that he shall not be liable to retire by rotation.MoreLess
    2 for0 against
  • Ratification of remuneration of Rs. 66,000/- plus applicable tax and reimbursement of out of pocket expenses payable to M/s G Sugumar and Co, Cost Accountants (Registration No. 102522), Chennai, appointed by the Board as Cost Auditors to conduct the audit of the cost records of the Company for the financial year 2024 - 25.MoreLess
    2 for0 against
  • Re-appointment of M/s. Deloitte Haskins and Sells LLP, Chartered Accountants (Firm registration number: 008072S) (Deloitte) as the Statutory Auditors of the Company for the second term of five consecutive years, who shall hold office from the conclusion of this 41st AGM till the conclusion of the 46th AGM to be held in the year 2029, at such remuneration.MoreLess
    2 for0 against
  • To appoint a Director in place of Dr. S Vijayabaskaran (DIN: 05139565), who retires by rotation and being eligible, offers himself for re-appointment.
    2 for0 against
  • To consider and adopt the Audited Financial Statements of the Company for the financial year ended 31st March 2024 together with the Reports of the Board of Directors and the Auditor thereon.
    2 for0 against
  • To consider re-appointment of Dr S Chandrakumar (DIN: 01867847) as Executive Chairman (Whole-Time) for a three year term commencing from 29th September 2024 to 28th September 2027 at a remuneration not exceeding Rs. 84,00,000/- per annum.MoreLess
    2 for0 against
  • To consider re-appointment of Dr S Manivannan (DIN: 00910804) as Managing Director for a three year term commencing from 01st October 2024 to 30th September 2027 at a remuneration not exceeding Rs. 84,00,000/- per annum.MoreLess
    2 for0 against

Mutual fund votes, meeting of 20 Jun 2024, 1 fund house

  • Appointment of Mr. Ravichandran Purushothaman (DIN: 06584433) as Non - Executive Independent Director of the Company for a period of 5 (five) years with effect from April 01,2024 till March 31, 2029, and that he shall not be liable to retire by rotation.MoreLess
    1 for0 against
  • Appointment of Mr. Sunil Satyapal Gulati (DIN:00016990) as Non - Executive Independent Director of the Company for a period of 5 (five) years with effect from April 01,2024 till March 31, 2029, and that he shall not be liable to retire by rotation.MoreLess
    1 for0 against

Mutual fund votes, meeting of 27 Sep 2023, 1 fund house

  • Appointment of Dr. S Vijayabaskaran (DIN: 05139565), as a Non-Executive Non-Independent Director of the Company.
    1 for0 against
  • Ratification of remuneration Rs.55,000/- plus applicable tax and reimbursement of out of pocket expenses paid to M/s G Sugumar & Co, Cost Accountants (Registration No. 102522), as Cost Auditors to conduct the audit of the cost records of the Company for the financial year 2022-23.MoreLess
    1 for0 against
  • Ratification of remuneration Rs.55,000/- plus applicable tax and reimbursement of out of pocket expenses paid to M/s G Sugumar & Co, Cost Accountants (Registration No. 102522), Chennai, appointed by the Board as Cost Auditors to conduct the audit of the cost records of the Company for the financial year 2023-24.MoreLess
    1 for0 against
  • To appoint a Director in place of Dr T Senthil Kumar (DIN: 01742558), who retires by rotation and being eligible, offers himself for re-appointment.
    1 for0 against
  • To receive, consider and adopt the Audited Financial Statements of the Company for the financial year ended 31st March 2023 together with the Report of the Board of Directors and the Auditors thereon.
    1 for0 against

Mutual fund votes, meeting of 28 Sep 2020, 1 fund house

  • To appoint a Director in place of Dr T Senthil Kumar (DIN: 01742558), who retires by rotation and being eligible, offers himself for re-appointment.
    1 for0 against
  • To approve limits of borrowing under section 180 (1) (c) and 180 (1) (a) of the Companies Act, 2013
    1 for0 against
  • To approve limits of investment(s), guarantee(s) and security (ies) under Section 186 of the Companies Act, 2013
    1 for0 against
  • To approve related party transactions under section 188 of the Companies Act, 2013 and Clause 23 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
    1 for0 against
  • To receive, consider and adopt the Audited Financial Statements of the Company for the financial year ended 31st March 2020 together with the Report of the Board of Directors and the Auditors thereon.
    1 for0 against

Each fund house counted once, from its own disclosure; the reasons are its own words.

Investor complaints and compliance

Quarter by quarter.

Investor complaints received and resolved, the company's own count

  • Received
  • Resolved

Open at the quarter's end

At most 1 complaint open, quarter to Sep 2025.
The board is made up as the listing rules require
Yes
The board has a regular chairperson
Yes
The company has a risk management committee
Yes
The chair is related to the managing director
No
The filing has a part on fines and penalties
No
The filing has a part on tax disputes
No
There was a cyber security incident in the quarter
No

The company's own answers in its filing.